Meluzio Michael Vincent
VP, Prin. Accounting Officer
Meluzio Michael Vincent has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Oct 15, 2026.
On the most recent filing, Meluzio Michael Vincent is listed as VP, Prin. Accounting Officer at Cue Biopharma, Inc. Inside the rolling window, Meluzio Michael Vincent reported no open-market purchases and 2 open-market sales totaling $201K in CUE. The largest disclosed transaction in the window is a sale of 5,628 CUE shares on Aug 13, 2026, worth $169K.
Companies traded
Other insiders at CUE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$201K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Meluzio Michael Vincent made?
Meluzio Michael Vincent has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Meluzio Michael Vincent trade?
Meluzio Michael Vincent has filed SEC Form 4 disclosures for 1 company, including CUE.
When was Meluzio Michael Vincent's most recent SEC Form 4 filing?
Meluzio Michael Vincent's most recent SEC Form 4 filing on Tracefour is dated Oct 15, 2026.
What is Meluzio Michael Vincent's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Meluzio Michael Vincent is listed as VP, Prin. Accounting Officer.
What is Meluzio Michael Vincent's total buy and sell value in the current window?
Inside the rolling retention window, Meluzio Michael Vincent bought $0 and sold $201K based on SEC Form 4 filings.
What was Meluzio Michael Vincent's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,628 CUE shares on 2026-08-13, worth $169K, per SEC Form 4 filings.